Ventum Capital Markets analyst Rob Goff thinks he has found a tariff turmoil winner in Calian Group (Calian Group Stock Quote, Chart, News, Analysts, Financials TSX:CGY). In a research update to clients April 9, Goff maintained his “Buy” rating and price target of $68.00 on CGY, implying a return of 64.7% at the time of […]

Source

Wait and see. That’s the advice from RBC Dominion Securities analyst Drew McReynolds on BCE (BCE Stock Quote, Chart, News, Analysts, Financials TSX:BCE), ahead of the company’s Q1 financials, due May 8. As reported by the Globe and Mail, McReynolds April 9 maintained his “Sector Perform” rating on BCE while cutting his price target on […]

Source

After taking a long look at the inquiry into Circle Medical’s billing practices by the U.S. Attorney’s Office, Raymond James analyst Michael W. Freeman says he believes the matter is “financially immaterial” to WELL Health Technologies (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) On March 28, WELL announced that its subsidiary Circle Medical […]

Source

New year, new CEO. Can Lip-Bu Tan make a difference for Intel (Intel Stock Quote, Chart, News, Analysts, Financials NASDAQ:INTC). Analyst Suji Desilva is taking a wait and see approach to INTC -the analyst April 4 maintained his “Neutral” rating and $20.00 price target on the stock- but he like some of what he sees […]

Source

Following a key product update, Raymond James analyst Michael W. Freeman remains bullish on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP). On April 7, MDP issued a press release on the commercialization progress of GRAFAPEX™ (Treosulfan ). Treosulfan is a chemotherapy drug primarily used as a conditioning agent before hematopoietic stem […]

Source

The new go-private price for Converge Technology Solutions (Converge Technology Solutions Stock Quote, Chart, News, Analysts, Financials TSX:CTS) is $6.00 and Ventum Capital Markets analyst Rob Goff thinks that is fair. On April 2, Converge reported that, owing to a competitive bid, H.I.G. Capital had agreed to raise its bid on CTS from $5.50 to […]

Source

He’s has a “Buy” rating on the stock, but TD Cowen analyst Vince Valentini thinks 2025 could be a rocky road for Rogers Communications (Rogers Communications Stock Quote, Chart, News, Analysts, Financials TSX:RCI.B). As reported by the Globe and Mail, Valentini April 1 reiterated his “Buy” rating and 12-month price target of $64.00 on Rogers. […]

Source

Fund manager Greg Newman of Newman Group ScotiaMcLeod says he is “going out on a limb” by making Telus (Telus Stock Quote, Chart, News, Analysts, Financials TSX:T) one of his top picks. Appearing on BNN Bloomberg’s “Market Call” March 28, Newman acknowledged that the reason for Telus’s sharp fall of late are no mystery. “You […]

Source

“The biggest Liberation Day winner”. That’s where Citi analyst James Hardiman thinks BRP (BRP Stock Quote, Chart News, Analysts, Financials TSX:DOO) stands in the North American travel and leisure sector. As reported by The Globe and Mail, the analyst April 4 raised his rating on BRP from “Sell” to “Neutral”, and raised his price target […]

Source

What’s the latest on Donald Trump’s tariffs? You might want to check your watch, not your calendar say economists at RBC. On April 2, 2025, President Donald Trump announced a new tariff policy imposing a universal 10% tariff on all imports, effective April 5th, with higher rates for specific countries. China faces a 34% tariff, […]

Source

Its fourth quarter results are in the books and Haywood analyst Neal Gilmer has maintained his “Buy” rating on Rubicon Organics (Rubicon Organics Stock Quote, Chart, News, Analysts, Financials TSXV:ROMJ). On April 1, ROMJ reported its Q4 and fiscal 2024 results. In the fourth quarter, the company posted Adjusted EBITDA of $1.6-million on revenue of […]

Source

Following the company’s fourth quarter results, RBC analyst Paul Treiber has cut his price target on BlackBerry (BlackBerry Stock Quote, Chart, News, Analysts, Financials NYSE:BB). On April 2, BB reported its Q4 and fiscal 2024 results. In the fourth quarter, the company posted Adjusted EBITDA of $21.1-million on revenue of $141.7-million. The stock fell sharply […]

Source

Following the company’s fourth quarter results, National Bank Financial analyst Rupert Merer has downgraded Exro Technologies (Exro Technologies Stock Quote, Chart, News, Analysts, Financials TSX:EXRO). On March 31, EXRO reported its Q4 and fiscal 2024 results. In the fourth quarter, the company posted revenue of $6.7-million, belwo the street estimate of $10.6-million. “2024 was a […]

Source

Following the company’s most recent acquisition, Haywood analyst Neal Gilmer has maintained his “Buy” rating on Organigram (Organigram Stock Quote, Chart, News, Analysts, Financials TSX:OGI). On April 1, OGI announced that it would enter the U.S. market via the acquisition of beverage company Collective Project Limited for $(C) $6.2-million. “The acquisition of Collective Project marks […]

Source

RBC analyst Paul Treiber is still not fully convinced that BlackBerry (BlackBerry Stock Quote, Chart, News, Analysts, Financials NYSE:BB) is having the renaissance suggested by its recently buoyant share price. On March 31, in a research update to clients, Treiber maintained his “Hold” rating and price target of (US) $4.00 on BlackBerry. On April 2, […]

Source

HEALWELL AI (HEALWELL AI Stock Quote, Chart, News, Analysts, Financials TSX:AIDX) has made an acquisition that will present the company with immediate upsell opportunities. That’s the opinion of Raymomd James analyst Michael W. Freeman, who in a research update to clients April reiterated his “Outperform 2” rating and price target of $3.00 on AIDX. On […]

Source

TD Cowen analyst Vince Valentini says he is feeling more bullish about Quebecor (Quebecor Stock Quote, Chart, News, Analysts, Financials TSX:QBR.B). As reported by the Globe and Mail, Valentini April 1 maintained his “Buy” rating and raised his price target on QBR from $40.00 to $45.00. “Given elevated confidence in the company’s balance sheet and […]

Source

Following the company’s fourth quarter results, Ventum Capital Markets analysts Andrew Semple has maintained his “Buy” rating on Vext Science (Vext Science Stock Quote, Chart, News, Analysts, Financials CSE:VEXT). On March 31, VEXT reported its Q4 and fiscal 2024 results. In the fourth quarter, the company posted Adjusted EBITDA of $3.24-million on revenue of $10.2-million, […]

Source

Delayed financials from WELL Health (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) mean an opportunity for investors. On March 28, WELL announced that its audited financial statements would be delayed by a request from Civil Division of the United States Attorney’s Office for the Northern District of California which is investigating certain billing […]

Source

Ahead of the company’s fourth quarter results, CIBC analyst Todd Coupland has maintained his “Buy” rating and $7.00 price target on BlackBerry (BlackBerry Stock Quote, Chart, News, Analysts, Financials NYSE:BB). Coupland raised his price target on BB from (US) $6.00 to $7.00 on February 24. On April 2, before the market open, BlackBerry will report […]

Source